|
产品描述
|
Certainly! Here's a structured outline to supplement and improve the product information for Recombinant Human IFN-alpha (2a):
Storage
- Temperature: Store at -20°C or below for long-term storage. For short-term use, it can be stored at 2-8°C.
- Protection from Light: Keep the product protected from direct light. Use amber vials or cover with aluminum foil if necessary.
- Stability: Once thawed, aliquot and refreeze any unused portions immediately. Avoid repeated freeze-thaw cycles to maintain stability.
- Shelf Life: When stored appropriately, the product remains stable for up to 12 months from the date of manufacture.
Product Description
- Nature: Recombinant Human IFN-alpha (2a) is a synthetic version of the naturally occurring interferon-alpha protein, produced using recombinant DNA technology.
- Source: Expressed in Escherichia coli or another suitable expression system.
- Purity: Greater than 95% purity as determined by SDS-PAGE and HPLC analyses.
- Formulation: Typically supplied as a lyophilized powder or in a buffered aqueous solution, containing stabilizers such as human serum albumin (HSA).
Key Features
- Activity: Exhibits antiviral, antiproliferative, and immunomodulatory activities.
- Potency: Demonstrated high biological activity in vitro and in vivo models.
- Consistency: Batch-to-batch consistency ensured through rigorous quality control processes.
- Safety: Endotoxin levels are minimized, suitable for research and clinical applications.
What's Included
- Product: Recombinant Human IFN-alpha (2a) in specified quantity (e.g., 10 µg, 100 µg, 1 mg).
- Documentation: Certificate of Analysis (CoA) detailing product specifications, purity, and activity.
- User Guide: Instructions for reconstitution, handling, and application.
- Optional: Stabilization buffer or reconstitution buffer, if not included in the formulation.
Applications
- Research: Used in studies of viral infections, cancer, and autoimmune diseases to understand IFN-alpha’s mechanisms of action.
- Clinical Trials: Potential therapeutic for chronic hepatitis B and C, certain types of cancer, and other conditions requiring modulation of the immune response.
- Diagnostics: Employed in assays and diagnostic tests measuring immune response and disease progression.
- Drug Development: Utilized in pharmaceutical research for the development of interferon-based treatments.
These enhancements aim to provide comprehensive and practical information for users, facilitating effective utilization and ensuring optimal performance of the product in various applications.
|